ProfileGDS4177 / 226878_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 46% 46% 41% 40% 43% 42% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated28.146
GSM603099KU-812 non-treated27.946
GSM603098KCL-22 Imatinib-treated21.9141
GSM603097KCL-22 non-treated21.4840
GSM603102JURL-MK1 Imatinib-treated24.4443
GSM603101JURL-MK1 non-treated23.2742